ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Potassium Carbonate → 2-{(2S)-2-[4-(5-methyl-[1,2,4]oxadiazol-3-yl)-phenyl]-morpholin-4-yl}-1H-[4,4']bipyrimidinyl-6-one

HRID 2045908
印刷

反応式

HRID 2045908 の反応式
Cl.[CH3:2][C:3]1[O:7][N:6]=[C:5]([C:8]2[CH:13]=[CH:12][C:11]([C@@H:14]3[O:19][CH2:18][CH2:17][NH:16][CH2:15]3)=[CH:10][CH:9]=2)[N:4]=1.Cl.[N:21]1([C:26](N)=[NH:27])C=CC=N1.C(N(CC)C(C)C)(C)C.C(O[C:41](=[O:51])[CH2:42][C:43](=O)[C:44]1[CH:49]=[CH:48][N:47]=[CH:46][N:45]=1)C.C(=O)([O-])[O-].[K+].[K+]>CN(C)C=O.C(O)C>[CH3:2][C:3]1[O:7][N:6]=[C:5]([C:8]2[CH:13]=[CH:12][C:11]([C@@H:14]3[O:19][CH2:18][CH2:17][N:16]([C:26]4[NH:27][C:41](=[O:51])[CH:42]=[C:43]([C:44]5[CH:49]=[CH:48][N:47]=[CH:46][N:45]=5)[N:21]=4)[CH2:15]3)=[CH:10][CH:9]=2)[N:4]=1
参加物実験手順後処理出典と根拠反応ノート

参加物

8

反応物 5

HCID 11430Potassium CarbonateHCID 81531DiisopropylethylamineHCID 2734672Pyrazole-1-carboxamidine monohydrochlorideHCID 11961458Ethyl 3-oxo-3-(pyrimidin-4-yl)propanoateHCID 66603801(2S)-2-(4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl)morpholine hydrochloride2 回

生成物 1

HCID 135910186
2-{(2S)-2-[4-(5-methyl-[1,2,4]oxadiazol-3-yl)-phenyl]-morpholin-4-yl}-1H-[4,4']bipyrimidinyl-6-one
収率 33%

試薬・触媒・溶媒 2

HCID 702Ethanol溶媒HCID 6228Dimethylformamide溶媒

実験手順

To a solution of (2S)-2-(4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl)morpholine hydrochloride (intermediate 13, 4.00 g, 14.2 mmol) and 1H-pyrazole-1-carboxamidine hydrochloride (2.19 g, 14.9 mmol) in N,N-dimethylformamide (14 ml) was added. N,N-diisopropylethylamine (4.05 g, 31.3 mmol) at room temperature and the solution was stirred for 4 hours. The solution was decanted with ether, then 3-oxo-3-pyrimidin-4-yl-propionic acid ethyl ester (3.59 g, 18.5 mmol), potassium carbonate (4.92 g, 35.6 mmol) and ethanol (30 ml) were added to the resulting solution. After refluxed for 18 hours, the solution was concentrated under reduced pressure. The residue was washed with water and the hot mixture of ethanol and 1N hydrochloric acid (1/1, v/v), and dried under reduced pressure to afford 2-{(2S)-2-[4-(5-methyl-[1,2,4]oxadiazol-3-yl)-phenyl]-morpholin-4-yl}-1H-[4,4′]bipyrimidinyl-6-one (1.94 g, 33%).

後処理

  1. customThe solution was decanted with ether
  2. temperatureAfter refluxed for 18 hours
  3. concentrationthe solution was concentrated under reduced pressure
  4. washThe residue was washed with water
  5. additionthe hot mixture of ethanol and 1N hydrochloric acid (1/1
  6. customv/v), and dried under reduced pressure

出典と根拠

ORDレコード
ord-698c32bb8c254a46a4c1c5a7996f0d20
出典データセット
uspto-grants-2013_11
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US08592417B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート